{"pub_date": "2016-01-29T00:00:00Z", "subsection_name": null, "lead_paragraph": "American regulators approved a new once-daily pill for the liver-destroying virus made by Merck, which said it would sell the drug at a lower list price than its competitors.", "print_page": "8", "document_type": "article", "byline": {"contributor": "", "person": [], "original": "By REUTERS", "organization": "REUTERS"}, "multimedia": [], "section_name": "Business Day", "headline": {"print_headline": "Merck Hepatitis Drug Approved", "main": "Hepatitis C Drug From Merck Is Approved"}, "source": "The New York Times", "blog": [], "word_count": "237", "web_url": "http://www.nytimes.com/2016/01/29/business/hepatitis-c-drug-from-merck-is-approved.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "American regulators approved a new once-daily pill for the liver-destroying virus made by Merck, which said it would sell the drug at a lower list price than its competitors.", "_id": "56abab5638f0d87a41957476", "abstract": "Food and Drug Administration approves hepatitis C drug Zepatier made by Merck; price is $54,600 for 12-week regimen.", "keywords": [{"rank": "1", "name": "organizations", "value": "Merck & Company Inc", "is_major": "Y"}, {"rank": "2", "name": "subject", "value": "Hepatitis", "is_major": "Y"}, {"rank": "3", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "Y"}, {"rank": "4", "name": "subject", "value": "Prices (Fares, Fees and Rates)", "is_major": "N"}]}